A Study to Investigate the Safety and Efficacy of LT-02 in Patients With Mesalamine Refractory Ulcerative Colitis (UC) (PROTECT-3)
patients will be taking part in this study
Drug: LT-02 Drug: LT-02 Placebo
GI Research Institute, Suite 770-1190 Hornby Street, Vancouver, British Columbia, Canada
The purpose of this study is to determine whether Phosphatidylcholine (LT-02) add on treatment is effective and safe for the induction of remission in ulcerative colitis patients refractory to standard treatment with mesalamine.